An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy (LaProS)
Rectal Prolapse, Procidentia
About this trial
This is an interventional treatment trial for Rectal Prolapse focused on measuring Laparoscopic surgery, Colorectal Surgery, Quality of Life, Rectal Prolapse, Anorectal Physiology
Eligibility Criteria
Inclusion Criteria:
- All patients with an indication for Laparoscopic Resection Rectopexy* for External Rectal Prolapse (Oxford Grade V)
Exclusion Criteria:
- Under 18 years of age
- Former rectosigmoid resection
- Former rectal prolapse surgery
- Rectosigmoid tumor
- Severe mental retardation
- Pregnant women
Sites / Locations
- The Florida Hospital
- Tampa General Hospital
- Cleveland Clinic Floria
- Oschner Clinic North Shore
- John Hopkins
- Lahey Medical Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Cohort 2
Cohort 1
Cohort 2 (two) will consist of 120 patients with an external rectal prolapse (Oxford Grade V)treated by Laparoscopic Resection Rectopexy (LRR). These patients will be included in the US centers involved in this study and treated by LRR.
Cohort one will consist of 120 patients with an external rectal prolapse (Oxford Grade V) which will be treated with Laparoscopic Ventral Rectopexy. As this is the standard treatment in the European centers involved in this study these patients will be selected in the participating centers in the Netherlands, Belgium and England.